Clinical Trial Update: Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of ledipasvir/sofosbuvir fixed-dose combination and sofosbuvir plus ribavirin in adults with chronic hepatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic HCV Infection | Phase 2 | Status: COMPLETED | Results posted: 2016-12-06